A Phase 3 interventional study of sulfasalazine 500 MG and corticosteroids in Oral Lichen Planus, Topical Sulfasalazine and Corticosteroids, sponsored by Cairo University. Active, not recruiting at 1 site in Egypt. Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-08-01.
Sponsored by Cairo University · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Lichen Planus, Oral by Cairo University — 1 open to participants now, 2 under way, 1 of them phase 3. Lichen Planus, Oral · Cairo University.
Among the 18 studies in Lichen Planus, Oral by Cairo University, this one is the 2nd largest by enrollment of the 10 interventional ones that give a count, is one of 2 that started in 2023, is one of 2 in phase 3, and was the 15th registered.
143 studies on the registry are indexed under Lichen Planus, Oral; 28 are open to participants now.
Browse Lichen Planus, Oral studies →1 of the 18 studies in Lichen Planus, Oral by Cairo University is open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
By country, each count listing its studies:
Of the 14 Lichen Planus, Oral studies recruiting now, 10 (71%) set no upper age limit and 2 (14%) stop at 75 or younger; 3 take children under 18; 3 take healthy volunteers.
This study: 30 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 46 is above the median of 40 across 102 interventional studies indexed under Lichen Planus, Oral.
Median enrollment 41 across the 10 interventional studies, 70 across the 8 observational. Of the 10 that completed or were terminated, 2 (20%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,952 studies on the registry; 1,463 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 18 studies in Lichen Planus, Oral by Cairo University, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Oral lichen planus (OLP) is a chronic inflammatory disease that affects the mucosal membrane. T-cell mediated damage against the mucosal epithelial cells is implicated in the pathogenesis of OLP, although the exact mechanism is unknown.
Sulfasalazine is extensively used in inflammatory bowel disease and is effective on immune-related inflammatory disease such as Crohn's disease, rheumatoid arthritis, and Behcet's disease. In spite of its effectiveness, the anti-inflammatory mechanism is not clearly understood.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.
After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hepatitis C tests
Hepatitis C is a virus that infects the liver. An HCV antibody test can stay positive after an infection has cleared (and is occasionally positive without one); an HCV RNA test shows whether the virus is there now.
After treatment, hepatitis C counts as cured when HCV RNA is still undetectable 12 weeks or more after the treatment ended. Studies often accept people cured this way.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The patients will use topical sulfasalazine prepared by dissolving one tablet of commercially available in 100 ml of distilled water 4 times per day as a mouth wash combined with topical corticosteroids 4 times per day as a topical gel in an alternate sequence.
Drug: sulfasalazine 500 MG · Drug: corticosteroids
The 23 patients categorized as control group (C group) will receive topical corticosteroids gel only 4 times per day. The treatment regimen will be continued for 4 weeks.
Drug: corticosteroids
The patients will use topical corticosteroids in addition to topical sulfasalazine 4 times per day.
Also known as: colosalazine
The patients will use topical corticosteroids 4 times per day.
Also known as: kenakort in orabase
NAS
Scale for pain assessment
Time frame: Every week for 4 weeks period
sign scoring scale of Thongprasom
Score for severity
Time frame: Every week for 4 weeks period
Plan to share: No — Because the research not published yet.
No publications or documents are linked to this record.
Started Mar 2023 (actual). Primary completion is estimated for Sep 2024, 18 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Sulfasalazine